Nereus Pharmaceuticals, Inc.
Records under this name other than patents Nereus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Nereus Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,067,616 | Total synthesis of salinosporamide A and analogs thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,572,606 | Biosyntheses of Salinosporamide a and Its Analogs and Related Methods of Making Salinosporamide a and Its Analogs Formerly held In force · High confidence | In force | High confidence | |
| US 10,793,824 | Salt Formulations for the Fermentation of Marine Microorganisms Formerly held In force · High confidence | In force | High confidence | |
| US 7,824,698 | Lyophilized Formulations of Salinosporamide A Formerly held In force · High confidence | In force | High confidence | |
| US 8,129,527 | Analogs of Dehydrophenylahistins and Their Theapeutic Use Formerly held In force · High confidence | In force | High confidence | |
| US 7,732,605 | Synthesis of Diketopiperazines Formerly held In force · High confidence | In force | High confidence | |
| US 8,003,802 | Total synthesis of Salinosporamide A and analogs thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,394,816 | Methods of Using [3.2.0] Heterocyclic Compounds and Analogs Thereof in Treating Waldenstrom's Macroglobulinemia Formerly held In force · High confidence | In force | High confidence | |
| US 8,986,971 | Salt Formulations for the Fermentation of Marine Microorganisms Formerly held In force · High confidence | In force | High confidence | |
| US 8,133,915 | INTERLEUKIN-1 and Tumor Necrosis Factor-Alpha Modulators; Syntheses of Such Modulators and Methods of Using Such Modulators Formerly held Term ended Term ended Jul 14, 2026 · Medium confidence | Term ended | Term ended Jul 14, 2026 | Medium confidence |